Purdue Pharma, creators of Oxycontin, developed and patented a new drug earlier this year aimed to help those addicted to opioids to stop top taking them. This new drug is a fast-acting form of buprenorphine. It’s a mild opioid intended to ease withdrawal symptoms.
Previously, the drug was prescribed in tablet or as fast-dissolving strips. This new prescription is a “wafer” that dissolves in the mouth within a few seconds.
Many have blamed Purdue Pharma for the epidemic of opioid painkiller addictions and deaths. Many are expressing outrage that the Sacklers, the family that owns Purdue, has profited from opioid addictions, and now plans to profit from the antidote.
Related:
- Opioids No Better than NSAIDs for Chronic Back or Arthritis Pain
- Puget Sound Mussels Contain Opioids, Antidepressants, and Chemotherapy Drugs
- Drug Firms Profiting From Addiction – Shipping Massive Quantities of Opioids To West Virginia
https://www.facebook.com/colbertlateshow/videos/2100395890224014
Michael Edwards is the founder, owner, editor-in-chief, and janitor for Organic Lifestyle Magazine. At age 17, Michael weighed more than 360 pounds. He suffered from allergies, frequent bouts of illness, and chronic, debilitating insomnia. Conventional medicine wasn’t working. While he restored his health through alternative medicine he studied natural health and became immersed in it.
Latest posts by Michael Edwards (see all)
- 40 Mile Trucker Protest Mandate, Trudeau Says Small Fringe Minority Holding Unacceptable Thoughts - January 31, 2022
- One Severe Allergic Reaction to COVID Vaccine Reported - December 17, 2020
- Donald Trump and His Wife Tested Positive for Coronavirus, Trump Hospitalized - October 2, 2020